Is it time to rethink the use of some of medicine's most time-honored instruments? Medscape's Eric J. Topol questions the value of 2 well-known icons of medicine.

EHRs are difficult, and scribes are becoming a popular solution. But does having a third person in the room get in the way of the doctor-patient relationship?

Dr. Mark Kris stresses that EGFR-targeted therapies provide no benefit in lung cancer patients who have no activating mutations, as evidenced in a recent study.

World-famous doctor Eduardo Rodriguez describes the deep emotional issues that arise when transplanting a donor face to a patient, the possibility of female-to-male face transplants, and more.

More than 60 medical societies have named hundreds of routine actions or tests that are unnecessary and shouldn't be done, speeding the momentum of this effort.

Dr. Mark Kris looks back at a fateful discovery and underscores the importance of testing for genetic mutations in every patient with non-small cell lung cancer.

Healthcare today is undeniably intertwined with industry. The challenge is to keep it professional and patient-centered.

Can British stoicism account for lower cancer survival rates in the UK vs Europe? Possibly, says Dr. David Kerr, who bemoans the poor UK showing after a 10-year initiative to improve survival.

Dr. George Lundberg analyzes President Obama's State of the Union address in regard to healthcare.

A systematic review provides practical clinical guidance for optimizing topical drug delivery to the paranasal sinuses.